Company & Sponsor Intelligence

The University of Queensland

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials5

Recruiting2

Completed2

Countries1

Therapeutic footprint

anxietyautismparkinsons

Indexed studies

NCT07114354Enhancing Utility of Neuropsychological Evaluation for Earlier and Effective Diagnosis of Dementia in Parkinson's Disease
parkinsons · NA

NCT05151601Combined Human Milk Oligosaccharides (HMOs) and Probiotics Intervention for Children With Autism
autism · AustraliaNA

NCT04643327Uncovering a Novel Therapeutic Target to Reduce Dementia Risk in Parkinson's Disease
parkinsons · AustraliaPHASE2

NCT04639141Combined Gut-brain Therapy for Children With Autism
autism · AustraliaNA

NCT05030285Telehealth Psychotherapy for Anxiety in Persons With Cognitive Impairment
anxiety · AustraliaNA

Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →